X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
radioligand assay (1896) 1896
humans (1646) 1646
animals (1470) 1470
male (1241) 1241
rats (805) 805
female (771) 771
index medicus (738) 738
pharmacology & pharmacy (533) 533
mice (478) 478
neurosciences (434) 434
adult (425) 425
middle aged (406) 406
rats, sprague-dawley (295) 295
binding (281) 281
ligands (279) 279
aged (271) 271
brain - metabolism (268) 268
dose-response relationship, drug (263) 263
structure-activity relationship (250) 250
chemistry, medicinal (241) 241
in vitro techniques (241) 241
radiology, nuclear medicine & medical imaging (235) 235
binding, competitive (232) 232
radioligand (202) 202
biochemistry & molecular biology (201) 201
brain (190) 190
radioligand therapy (187) 187
radioligand assay - methods (184) 184
positron-emission-tomography (174) 174
pet (167) 167
oncology (166) 166
protein binding (166) 166
psychiatry (165) 165
expression (164) 164
cell line (160) 160
receptors (158) 158
radioligand binding (157) 157
rats, wistar (157) 157
kinetics (156) 156
positron emission tomography (148) 148
receptor (147) 147
disease models, animal (145) 145
binding sites (142) 142
cricetinae (141) 141
brain - drug effects (139) 139
prostate cancer (138) 138
tritium (138) 138
in-vivo (137) 137
time factors (129) 129
adolescent (123) 123
cho cells (119) 119
cancer (118) 118
article (116) 116
therapy (114) 114
endocrinology & metabolism (113) 113
clinical neurology (112) 112
analysis (111) 111
rat (111) 111
rat-brain (111) 111
positron-emission tomography (110) 110
autoradiography (105) 105
binding, competitive - drug effects (103) 103
cells, cultured (103) 103
psma (102) 102
iodine radioisotopes (99) 99
cricetulus (96) 96
schizophrenia - drug therapy (95) 95
molecular structure (93) 93
tissue distribution (93) 93
aged, 80 and over (92) 92
stereoisomerism (91) 91
guinea pigs (90) 90
alzheimers-disease (88) 88
cell line, tumor (87) 87
dopamine (87) 87
serotonin (86) 86
cells (85) 85
brain - diagnostic imaging (82) 82
transfection (80) 80
alzheimer's disease (79) 79
immunohistochemistry (79) 79
models, molecular (79) 79
in-vitro (78) 78
medicine & public health (78) 78
administration, oral (76) 76
schizophrenia (76) 76
cerebral cortex - metabolism (75) 75
chemistry, organic (75) 75
pharmacology (75) 75
radioimmunoassay (75) 75
binding-sites (74) 74
depression (74) 74
research (74) 74
tumor cells, cultured (74) 74
antagonist (73) 73
inhibition (73) 73
piperazines - pharmacology (72) 72
positron-emission tomography - methods (70) 70
antagonists (69) 69
motor activity - drug effects (69) 69
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2758) 2758
German (33) 33
Russian (21) 21
French (16) 16
Japanese (11) 11
Serbian (3) 3
Bulgarian (2) 2
Chinese (2) 2
Hungarian (2) 2
Italian (2) 2
Dutch (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 08/2017, Volume 44, Issue 9, pp. 1473 - 1479
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 01/2017, Volume 58, Issue 1, pp. 85 - 90
Lu-177-labeled PSMA-617 is a promising new therapeutic agent for radioligand therapy (RLT) of patients with metastatic castration resistant prostate cancer... 
STATISTICS | DOCETAXEL | mCRPC | prostate cancer | PSMA | GA-68-PSMA LIGAND | PSMA-617 | radioligand therapy | CLINICAL-TRIALS | PET/CT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ENZALUTAMIDE | ABIRATERONE
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 07/2016, Volume 57, Issue 7, pp. 1006 - 1013
The objective of this study was to analyze the safety and efficacy of the Lu-177-labeled DOTAGA-based prostate-specific membrane antigen (PSMA) ligand... 
RADIATION-DOSIMETRY | SURVIVAL | PSMA INHIBITOR | PSMA | GA-68 | RECOMMENDATIONS | radioligand therapy | PET/CT | theranostics | RECEPTOR RADIONUCLIDE THERAPY | TISSUES | PROBE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Journal Article
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 10/2017, Volume 58, Issue 10, pp. 1624 - 1631
The aim of this study was to develop a treatment protocol for Ac-225-PSMA-617 a-radiation therapy in advanced-stage, metastatic castration-resistant prostate... 
RADIATION-DOSIMETRY | MEMBRANE ANTIGEN | EFFICACY | BIODISTRIBUTION | EMITTERS | PSMA INHIBITOR | PSMA | targeting | prostate cancer | LU-177-DKFZ-PSMA-617 | RADIOLIGAND THERAPY | RADIONUCLIDE THERAPY | Ac-225 | TISSUES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 05/2018, Volume 59, Issue 5, pp. 795 - 802
The aim of this evaluation was to identify the first indicators of efficacy for Ac-225-labeled prostate-specific membrane antigen (PSMA)-617 therapy in a... 
DOSIMETRY ESTIMATE | targeting therapy | MEMBRANE ANTIGEN | PLACEBO-CONTROLLED PHASE-3 | SURVIVAL ANALYSIS | PSMA | prostate cancer | RADIOLIGAND THERAPY | RADIONUCLIDE THERAPY | CLINICAL-TRIALS | TRIALS WORKING GROUP | DOUBLE-BLIND | Ac-225 | ABIRATERONE ACETATE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Seminars in Nuclear Medicine, ISSN 0001-2998, 07/2019, Volume 49, Issue 4, pp. 302 - 312
Journal Article
Seminars in Nuclear Medicine, ISSN 0001-2998, 07/2019, Volume 49, Issue 4, pp. 313 - 325
Journal Article
European Urology, ISSN 0302-2838, 06/2019, Volume 75, Issue 6, pp. 920 - 926
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) is increasingly being used in metastatic castration-resistant prostate cancer... 
Radioligand therapy | Metastatic castration-resistant prostate cancer | Lutetium | Prostate-specific membrane antigen
Journal Article
Journal of Medical Imaging and Radiation Oncology, ISSN 1754-9477, 08/2019, Volume 63, Issue 4, pp. 538 - 545
Journal Article
Circulation, ISSN 0009-7322, 03/2009, Volume 119, Issue 9, pp. 1231 - 1240
Journal Article